CA2 and osteosarcoma: For comparison of anticancer activity, we included acetazolamide (AAZ), recognized for its inhibition of CAII, IV, VII, and XII expression [27], and cisplatin, known for its anticancer properties in blocking osteosarcoma invasion [28].